Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Slaton

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Urology|September 1, 1997
Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladderJ W Slaton, C P Dinney, R W Veltri, et al.
The American Journal of Pathology|February 13, 2001
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinomaJ W Slaton, K Inoue, P Perrotte, et al.
Oncology Reports|December 15, 2000
Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladderJ I Izawa, J W Slaton, D Kedar, et al.
Urology|December 31, 1997
Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinomaJ W Slaton, M D Balbay, D A Levy, et al.
Cancer Research|April 29, 2000
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancerK Inoue, J W Slaton, S J Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxelK Inoue, J W Slaton, D W Davis, et al.
The Journal of Urology|March 21, 2001
Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancerJ W Slaton, N Morgenstern, D A Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinomaK Inoue, J W Slaton, P Perrotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladderJ W Slaton, T Karashima, P Perrotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancerK Inoue, J W Slaton, B Y Eve, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Urology|September 1, 1997
Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladderJ W Slaton, C P Dinney, R W Veltri, et al.
The American Journal of Pathology|February 13, 2001
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinomaJ W Slaton, K Inoue, P Perrotte, et al.
Oncology Reports|December 15, 2000
Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladderJ I Izawa, J W Slaton, D Kedar, et al.
Urology|December 31, 1997
Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinomaJ W Slaton, M D Balbay, D A Levy, et al.
Cancer Research|April 29, 2000
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancerK Inoue, J W Slaton, S J Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxelK Inoue, J W Slaton, D W Davis, et al.
The Journal of Urology|March 21, 2001
Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancerJ W Slaton, N Morgenstern, D A Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinomaK Inoue, J W Slaton, P Perrotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladderJ W Slaton, T Karashima, P Perrotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancerK Inoue, J W Slaton, B Y Eve, et al.
Pageof 3